Nutrition Reviews 1993: Vol 51 Index

11 Pages·1993·2.7 MB·English

December 1993: 362-369
Subject Index to Volume 51
A prefix indicating the type of contribution may precede the page number as follows:
LRA: Lead Review Article SR: Special Report
SA: Special (Signed) Article NGR: Nutrition Grand Round
LE: Letter to the Editor NSP: Nutrition-Science-Policy
An eniry without a prefix is a Brief Critical Review.
ACQUIRED IMMUNODEFICIENCY SYNDROME W.O. Atwater Centennial Celebration Symposium,
(AIDS) 125
energy expenditure in, NGR226 ANTIHISTAMINE
vitamins and minerals in, NGR226 vitamin C as, LRA313
weight loss in, NGR226 ANTIOXIDANTS
ADOLESCENTS cataracts in women and intake of, 84
calcium intake and skeletal growth of, SA171 possible role in preventing and treating ALS, 243
in developing countries, growth predictors for, LRA255 APOLIPOPROTEIN A-!IV
AGING role in inhibition of food consumption, 273
body composition and, LRAI APOPROTEIN A-1
changes in immune response with, LRA217 role in ethanol-induced protection against coronary
changes in neuroendocrine and immune modulators heart disease, 151
of metabolism during, LRAI ARGININE
lipofuscin accumulation in human tissues with, 205, supplemental, effect on immune function after
LE348 surgery, 54
role of iron in brain in disorders associated with, ASCORBIC ACID (see also VITAMIN C)
LRAI57 bioavailability of, in foods and supplements, 301
vitamin B, deficiency in, LRA217 cardiovascular risk and intake of, LRA313
ALCOHOL CONSUMPTION cataracts in women and intake of, 84
factor in neuropathy epidemic in Cuba, SA349 decreased cataract risk and formation with intake of,
ALZHEIMER’S DISEASE LRA313
role of iron in, LRA157 role against cancer, LRA313
AMINO ACIDS uptake of, by human neutrophils, 337
two-step absorptive process for, LRA9S5 ATHEROGENESIS
AMYOTROPHIC LATERAL SCLEROSIS (ALS) lipid oxidation products in food and, LRA33
copper/zinc superoxide dismutase (SOD1) gene low-copper diet and, 88
mutations associated with, 243 ATHEROSCLEROSIS
ANDROGENS role of oxidation of polyunsaturated fatty acids in,
age-related body composition and changes in, LRAI LRA33
ANION EXCHANGE RESINS AVERAGE REQUIREMENT
as cholesterol-lowering medication, NSP246 proposed value for European Community nutrient
ANNOUNCEMENTS intake, NSP209
First Independent Conference of the Society for the
Study of Ingestive Behavior, 28 BIFIDOBACTERIA
Hermes Promotion Award for Research on Minerals fermentation of oligofructose by, SA137
1993, 156 BODY COMPOSITION
International Advanced Course in the Epidemiology effect of aging on, LRAI
of Geriatric Nutrition, 156 BODY FAT
Recent Advances in Nutritional Management of zinc supplementation of growth-retarded children and
Gastrointestinal Disorders, 156 increase in, 268
13th Annual Bristol-Myers Squibb/Mead Johnson BODY MASS INDEX (BMI)
Nutrition Research Symposium: Nutritional desirable body weight defined in, LRA127
Assessment of Elderly Populations—Measure BODY WEIGHT
and Function, 253 mortality and, LRA127
Nutrition Reviews, Vol. 51, No. 12
December 1993: 362-369
Subject Index to Volume 51
A prefix indicating the type of contribution may precede the page number as follows:
LRA: Lead Review Article SR: Special Report
SA: Special (Signed) Article NGR: Nutrition Grand Round
LE: Letter to the Editor NSP: Nutrition-Science-Policy
An eniry without a prefix is a Brief Critical Review.
ACQUIRED IMMUNODEFICIENCY SYNDROME W.O. Atwater Centennial Celebration Symposium,
(AIDS) 125
energy expenditure in, NGR226 ANTIHISTAMINE
vitamins and minerals in, NGR226 vitamin C as, LRA313
weight loss in, NGR226 ANTIOXIDANTS
ADOLESCENTS cataracts in women and intake of, 84
calcium intake and skeletal growth of, SA171 possible role in preventing and treating ALS, 243
in developing countries, growth predictors for, LRA255 APOLIPOPROTEIN A-!IV
AGING role in inhibition of food consumption, 273
body composition and, LRAI APOPROTEIN A-1
changes in immune response with, LRA217 role in ethanol-induced protection against coronary
changes in neuroendocrine and immune modulators heart disease, 151
of metabolism during, LRAI ARGININE
lipofuscin accumulation in human tissues with, 205, supplemental, effect on immune function after
LE348 surgery, 54
role of iron in brain in disorders associated with, ASCORBIC ACID (see also VITAMIN C)
LRAI57 bioavailability of, in foods and supplements, 301
vitamin B, deficiency in, LRA217 cardiovascular risk and intake of, LRA313
ALCOHOL CONSUMPTION cataracts in women and intake of, 84
factor in neuropathy epidemic in Cuba, SA349 decreased cataract risk and formation with intake of,
ALZHEIMER’S DISEASE LRA313
role of iron in, LRA157 role against cancer, LRA313
AMINO ACIDS uptake of, by human neutrophils, 337
two-step absorptive process for, LRA9S5 ATHEROGENESIS
AMYOTROPHIC LATERAL SCLEROSIS (ALS) lipid oxidation products in food and, LRA33
copper/zinc superoxide dismutase (SOD1) gene low-copper diet and, 88
mutations associated with, 243 ATHEROSCLEROSIS
ANDROGENS role of oxidation of polyunsaturated fatty acids in,
age-related body composition and changes in, LRAI LRA33
ANION EXCHANGE RESINS AVERAGE REQUIREMENT
as cholesterol-lowering medication, NSP246 proposed value for European Community nutrient
ANNOUNCEMENTS intake, NSP209
First Independent Conference of the Society for the
Study of Ingestive Behavior, 28 BIFIDOBACTERIA
Hermes Promotion Award for Research on Minerals fermentation of oligofructose by, SA137
1993, 156 BODY COMPOSITION
International Advanced Course in the Epidemiology effect of aging on, LRAI
of Geriatric Nutrition, 156 BODY FAT
Recent Advances in Nutritional Management of zinc supplementation of growth-retarded children and
Gastrointestinal Disorders, 156 increase in, 268
13th Annual Bristol-Myers Squibb/Mead Johnson BODY MASS INDEX (BMI)
Nutrition Research Symposium: Nutritional desirable body weight defined in, LRA127
Assessment of Elderly Populations—Measure BODY WEIGHT
and Function, 253 mortality and, LRA127
Nutrition Reviews, Vol. 51, No. 12
BODY WEIGHT CHANGE CHOLECYSTOKININ (CCK)
mortality and, LRA127 inhibitory effect on fat intake, 181
BONE MASS CHOLESTEROL
dietary calcium intake during growth and, SA171 atherogenesis and oxidation products of, LRA33
BOVINE SERUM ALBUMIN ANTIBODIES effect of trans fatty acids on levels of, 340, 344
destruction of pancreatic insulin-producing beta cells ethanol-induced apo A-1! secretion increases efflux of,
by, 79 151
BRAIN food label health claims with respect to coronary
effect of vitamin B, deficiency on development of, heart disease and, NSP90
LRA193 recommendations for diagnosis and treatment of
iron distribution in, LRA157 abnormalities in, NSP246
BREAST-FED INFANTS vitamin C intake lowers, LRA313
cerebral cortex docosahexaenoic acid levels in, 238 CHRONIC INFLAMMATION
decreased incidence of otitis media in, 275 changes in neuroendocrine and immune modulators
health and nutritional status of, 52 of metabolism in patients with, LRA1
CHYLOMICRONS
CACHEXIA suppressive effect on food consumption, 273
human immunodeficiency virus and, NGR226 CIGARETTE SMOKING
CALCIUM body weight, mortality, and, LRA127
bone mass and, SAI171 factor in neuropathy epidemic in Cuba, SA349
food label health claims with respect to osteoporosis COBALAMIN NEUROPATHY
and, NSP90 role of S-adenosylmethionine deficiency in, NGR12
growth and dietary intake of, SA171 COLON CANCER
CALCIUM SUPPLEMENTATION ascorbic acid as protection against, LRA313
dietary, effect on risk of colon cancer, 109, LE213 effect of dietary calcium supplementation on risk for,
hip fractures in elderly women prevented by, 183 109, LE213
CANCER effect of fish oil supplementation on risk for, 241
ascorbic acid as protection against, LRA313 fiber and, NSP57
FDA aut..orization of food labeling health claim with hyperproliferation in persons at risk for, 241
respect to, NSP90 COLORECTAL CANCER
CARDIAC ARRHYTHMIA ascorbic acid as protection against, LRA313
in rats, dietary fatty acids protect against, 271 dietary fiber decreases risks for, 147
CARDIOVASCULAR DISEASE COPPER ABSORPTION DISORDER
ascorbic acid intake and, LRA313 Menkes disease caused by, 235
copper deficiency and, 88 COPPER DEFICIENCY
dietary fatty acids protect against, 271 effect on interleukin-2 production, 307
trans fatty acids and, 340, 344 hypercholesterolemia and, 305
B-CAROTENE increase in aortic lipid peroxides in rats caused by, 88
cataracts in women and intake of, 84 increase in glutathione concentration and HMG-CoA
colorectal cancer risk and dietary intake of, 147 reductase activity caused by, 305
dietary equivalence to retinol, SA199 vascular defects and, 188
CAROTENOIDS CORONARY HEART DISEASE
bioavailability and bioconversion of, SA199 dietary fatty acids protect against, 271
plant sources versus chemical, human uptake of, ethanol consumption and lower incidence of, 151
SA199 FDA authorization of food labeling health ciaim with
CATARACT respect to, NSP90
antioxidant nutrition in women and incidence of, 84 National Cholesterol Education Program risk factors
ascorbic acid intake and decreased risk and formation for, NSP246
of, LRA313 normal iron status and risk of, 112
CATS recommendations for diet and drug therapy for, NSP246
age-associated loss of carrier-mediated intestinal role of red wine consumption in France in lower
taurine transport in, 22 incidence of, 185
CD4* CELL PROLIFERATION vitamin E supplementation reduces risk and mortality
copper-deficiency-induced impaired production of of, 333
IL-2 decreases, 307 CORTISOL
CELLULAR RETINOL-BINDING PROTEIN TYPE age-related body composition and changes in, LRA1
II (CRBPII) GENE COW’S MILK
9-cis-retinoic acid as activator of, 81 effect on infants, 79
CHILDREN insulin-dependent diabetes mellitus and, 79
calcium intake and skeletal growth of, SA171 CUBA
Iraqi, malnutrition in, SA74 food shortages and optic and peripheral neuropathy
of developing countries, growth failure of, 327 epidemic in, SA349
Nutrition Reviews, Vol. 51, No. 12
CYTOKINES ELECTRON TRANSPORT
age-related body composition and changes in, LRAI pyrroloquinoline quinone (PQQ) in mammalian
systems and, LE26
ENERGY EXPENDITURE
DAILY REFERENCE VALUES
self-reported versus actual, in obese subjects, SA296
FDA’s final regulations on nutritional labeling and,
ENERGY INTAKE
SR101
European Community guidelines for, NSP209
DEMYELINATION
ENTERAL NUTRITION
role of S-adenosylmethionine deficiency in, NGR12
nutritional support of HIV-infected persons using,
DEVELOPING COUNTRIES
NGR226
efficiency of vitamin A utilization from plant
ENVIRONMENT
carotenoids in, SA199
role in growth failure in children in developing
growth failure of children in, SA327
countries, SA327
marginal malnutrition and human function in,
ETHANOL
LRA255
apo A-1 secretion in human hepatocytes stimulated
zinc deficiency in, 268
by, 151
DIABETES MELLITUS
cardioprotective effect of, 151
insulin-dependent, cow’s milk and, 79
EUROPEAN COMMUNITY
DIET
nutrient and energy intakes for, NSP209
compliance with, 16
EXERCISE
high-iron, effect on manganese status, 86
effect on age-related body composition, LRAI
human function and, LRA255
effect on lean body mass, LE25
in obese subjects, self-report versus controlled
in obese subjects, self-report versus controlled
measurements, SA296
measurements, SA296
LDL cholesterol lowered using, NSP234
low-copper, increase in aortic lipid peroxides in rats
FAMINE RELIEF
fed, 88
recommendations dealing with, NSP116
maternal, effect on infant outcome, LRA255
FAT INTAKE
vegetarian, nephrotic syndrome treated by, 44
inhibitory effect of cholecystokinin on, 181
DIETARY FAT
FATTY ACIDS (see FREE FATTY ACIDS,
food label health claims with respect to cancer and,
MONOUNSATURATED FATTY ACIDS,
NSP90
POLYUNSATURATED FATTY ACIDS,
DIETARY SUPPLEMENTS
SATURATED FATTY ACIDS, SHORT-CHAIN
bioavailability of ascorbic acid from, 301
FATTY ACIDS, trans FATTY ACIDS)
FDA’s proposed regulations of, NSP278, NSP310
FERRITIN
safety limits for intake of, NSP278
response to iron status, LRA65
1,25-DIHYDROXYVITAMIN D, RECEPTOR
risk for heart disease and plasma concentration of,
role of 9-cis-retinoic acid receptor in regulation of
112
gene response to, 303
role in iron distribution in brain, LRA157
DOCOSAHEXAENOIC ACID
FIBER
in cerebral cortex of formula-fed versus breast-fed
colon cancer and, NSP57
infants, 238
dietary, colorectal cancer risk and, 147
DOSE-RESPONSE CURVES
nondigestable, biochemistry of, SA137
balance of essentiality and toxicity of trace elements
FISH OILS
shown by, LRA287
immune function of, LE24
intestinal hyperproliferation reduced by
EGYPT supplementation of, 241
study of marginal malnutrition and human function marine, ulcerative colitis treated by, 47
in, LRA255 protection against cardiovascular disease, 271
EICOSANOIDS FOLATE
effect of fish oil on synthesis of, in ulcerative colitis FDA’s policy on, NSP358
patients, 47 FOOD
ELDERLY atherogenesis and lipid oxidation products in, LRA33
changes in immune response in, LRA2:7 bioavailability of ascorbic acid from, 301
changes in neuroendocrine and immune modulators colon cancer and fiber content of, NSP57
of metabolism in, LRA1 FDA’s final regulations on health claims for, NSP90
risk of infection and aging immune response in, 106 FDA’s final regulations on nutritional labeling of,
supplementation with vitamin D, and calcium SR101
prevents hip fractures in, 183 reducing disease in, NSP346
trends in food consumption by, 20 FOOD AND DRUG ADMINISTRATION (FDA)
vitamin and mineral supplementation in, 106 proposed regulations of dietary supplements,
vitamin B, status in, LRA217 NSP278, NSP310
364 Nutrition Reviews, Vol. 51, No. 12
regulations for health claims for foods, NSP90 HIGH DENSITY LIPOPROTEINS (HDL) see HDL
regulations for nutritional labeling of foods, SR101 CHOLESTEROL
FOOD CONSUMPTION HIP FRACTURES
by elderly, trends in, 20 in elderly women, vitamin D, and calcium
per capita food supply data versus individual, 206 supplementation prevent, 183
FOOD INTAKE HMG-CoA REDUCTASE
in AIDS and HIV-positive patients, NGR226 hepatic, copper-deficiency-induced
inhibitory effect of cholecystokinin on, 181 hypercholesterolemia increases activity of, 305
per capita food supply data versus individual HMG CoA REDUCTASE INHIBITORS
consumption, 206 as LDL cholesterol-lowering medication, NSP246
role of apolipoprotein A-IV in, 273 HUMAN FUNCTION
self-reported versus actual, in obese subjects, SA296 effect of marginal malnutrition in developing
FOOD LABELS countries on, LRA255
FDA final regulation on health claims on, NSP90 HUMAN GROWTH HORMONE
FDA final regulation on nutrition information on, age-related body composition and changes in, LRA1
SR101 nutritional status of HIV-infected patients altered by,
FOOD SHORTAGE NGR226
factor in neuropathy epidemic in Cuba, SA349 HUMAN HEPATOCYTES
FORMULA-FED INFANTS ethanol-stimulated apo A-1 secretion in, 151
cerebral cortex docosahexaenoic acid levels in, 238 HUMAN IMMUNODEFICIENCY VIRUS (HIV)
health and nutritional status of, 52 INFECTION
FREE FATTY ACIDS nutritional status compromised by, NGR226
feedback control of lipoprotein lipase activity by, 18 vitamin B, deficiency and, LRA217
FRENCH PARADOX HUMAN NEUTROPHILS
inhibition of LDL oxidation by phenolic substances uptake of ascorbic acid by, 337
in red wine as clue for, 185 HUNGER
FRUITS world declaration on, SR41
FDA regulation of health claims of, NSP90 HYPERLIPIDEMIA
of nephrotic syndrome, vegetarian diet for treatment
GLUCOSE of, 44
effect of vitamin E supplementation on utilization of, HYPERPROLIFERATION
339 in colonic crypts, effect of fish oil supplementation
GLUTAMINE on, 241
intestinal mucosal immune function enhanced by total HYPERSENSITIVITY SKIN RESPONSE
parenteral nutrition enriched by, 152 delayed-type, reduced with vitamin B, deficiency,
GLUTATHIONE LRA217
copper-deficiency-induced hypercholesterolemia HYPERTENSION
increases metabolism of, 305 FDA regulation of food label health claim associating
GROWTH sodium and, NSP90
calcium intake requirements and, SA171 vitamin C and, LRA313
effect of mild zinc deficiency on, 268 HYPOVITAMINOSIS A
in developing countries, role of environmental efficiency of plant sources of vitamin A in
contamination in failure, SA327 countering, SA199
of children in developing countries, predictors of,
LRA255 IMMUNE FUNCTION
GUATEMALA effect of arginine on following surgery, 54
effect of zinc on growth performance of children in, 268 effect of copper deficiency on, 307
of fish oil to Salmonella infection, LE24
HDL CHOLESTEROL of intestinal mucosa, effect of glutamine in parenteral
effect of trans fatty acids on levels of, 340, 344 solutions on, 152
recommendations for diagnosis and treatment of role of vitamin B, deficiency in, LRA217
abnormalities in, NSP246 IMMUNE RESPONSE
role in ethanol-induced protection against coronary against environmental contamination, effect on
heart disease, 151 growth, SA327
HEALTH CLAIMS humoral and cell-mediated, effect of vitamin B,
FDA’s final regulations on, NSP90 deficiency on, LRA217
of dietary supplements, FDA’s proposed regulations of elderly, vitamin B, deficiency and, LRA217
for, NSP278, NSP310 of elderly, nutrient-induced improvement in, 106
of folate, FDA’s proposed regulations on, NSP358 vitamin C and, LRA313
HEMEPROTEINS IMMUNOSTIMULATION
riboflavin protects tissues from oxidative injury by contaminated environment, effect on growth,
caused by, 149 SA327
Nutrition Reviews, Vol. 51, No. 12
INFANTS role of oxidation of in atherosclerosis, LRA33
calcium intake and skeletal growth of, SA171 vitamin C as antioxidant against oxidation of,
effect of cow’s milk on, 79 LRA313
effect of maternal diet on outcome of, LRA255 LEAD REVIEW ARTICLES
effect of maternal vitamin B, deficiency on behavior Allen, LH: ‘‘The Nutrition CRSP: What Is Marginal
of, LRA193 Malnutrition, and Dies It Affect Human
in developing countries, growth predictors for, Function?’’ LRA255
LRA255 Beard, JL, Connor, JR, and Jones, BC: ‘‘Iron in the
Iraqi, malnutrition in, SA74 Brain,’ LRA157
INFECTIOUS DISEASES Christensen, HN: ‘‘Amino Acid Nutrition: A
supplementation-induced improved immune response Two-Step Absorptive Process,’” LRA95
reduces risk of, 106 Gershoff, SN: ‘Vitamin C (Ascorbic Acid): New
vitamin C and, LRA313 Roles, New Requirements?’’ LRA313
INSULIN Guilarte, TR: Vitamin B, and Cognitive
age-related body composition and changes in, LRAI Development: Recent Research Findings from
effect of vitamin E on hepatic response to, 339 Human and Animal Studies,’’ LRA193
INTERLEUKIN-1 Kubow, S: “‘Lipid Oxidation Products in Food and
age-related body composition and changes in, LRAI Atherogenesis,’’ LRA33
INTERLEUKIN-2 Kushner, RF: Body Weight and Mortality,’” LRA127
effect of copper deficiency on production of, 307 Mertz, W: ‘‘Essential Trace Metals: New Definitions
INTERMEDIARY METABOLISM Based on New Paradigms,’’ LRA287
role of new retinoic acid receptors (RXRs) in, 81 Munro, H: ‘The Ferritin Genes: Their Response to
INTERNATIONAL CONFERENCE ON NUTRITION Iron Status,’ LRA65
nongovernmental perspective on, NSP118 Rall, LC, and Meydani, SN: “‘Vitamin B, and
review of, NSP122 Immune Competence,’’ LRA217
INTESTINAL MUCOSA Roubenoff, R, and Rall, LC: ‘‘Humoral Mediation of
glutamine-enriched TPN enhances immune function Changing Body Composition During Aging and
of, 152 Chronic Inflammation,’’ LRA1
INULIN LEAN BODY MASS
biochemistry of oligofructose derived from, SA137 aging and, LRAI
IRAQ effect of aerobic and strengthening exercise on, LE25
malnutrition in children of, after Gulf War, SA74 LETTERS TO THE EDITOR
IRON Fliickiger, R: “PQQ and Electron Transport in
dietary heme and nonheme, effect on manganese Mammalian Systems,’’ LE26
status, 86 Fritsche, KL, Huang, S-C, and Misfeldt, M: ‘‘Fish
in central nervous system, LRA157 Oil and Immune Function,’’ LE24
response of ferritin genes to cellular increase in, Lipkin, M, and Newmark, H: ‘‘Calcium and Colon
LRA65 Cancer,”’ LE213
risk for heart disease and normal status of, 112 Roubenoff, R, and Evans, WJ: ‘‘Exercise and Lean
vitamin C and absorption of, LRA313 Weight,’’ LE25
IRON DEFICIENCY Wolf, G: ‘‘The Structure of the Age Pigment,
role in attention deficit and behavior, LRA157 Lipofuscin, and Its Accumulation Site in the
role in brain metabolism, LRA157 Human Eye,’’ LE348
IRON-DEFICIENCY ANEMIA LEUKOCYTES
role in increased risk of preterm delivery, 49 vitamin C effects on, LRA313
IRON REGULATORY ELEMENT BINDING LIPID OXIDATION PRODUCTS
PROTEIN (IRE-BP) atherogenesis and, LRA33
effect on ferritin mRNA translation, LRA65 LIPID PEROXIDES
copper deficiency and increase in, 88
KENYA LIPOFUSCIN
study of marginal malnutrition and human function identification of compound in, 205, LE348
in, LRA255 LIPOPROTEIN LIPASE
feedback control by free fatty acids of activity of, 18
LACTATE LIPOXYGENASE METABOLITES
as product of oligofructose fermentation, metabolism role in pathogenesis of ulcerative colitis, 47
of, SA137 LONG-TERM POTENTIATION
LDL CHOLESTEROL role of N-methyl-D-aspartate (NMDA) receptors in,
effect of trans fatty acid intake on level of, 340, 344 LRA193
recommendations for diagnosis and treatment of LOW BIRTH WEIGHT
abnormalities in, NSP246 iron-deficiency anemia in increased risk of, 49
red wine phenolic compounds inhibit oxidation of, LOW DENSITY LIPOPROTEINS (LDL) see LDL
185 CHOLESTEROL
Nutrition Reviews, Vol. 51, No. 12
LOWEST OBSERVED ADVERSE EFFECT LEVEL NATIONWIDE FOOD CONSUMPTION SURVEYS
(LOAEL) trends in food consumption by elderly shown by, 20
for nutrients, data acceptability criteria and use of per capita food supply data versus individual
availability for identification of, NSP278 consumption in, 206
LOWEST THRESHOLD INTAKE NEPHROTIC SYNDROME
proposed value for European Community nutrient vegetarian diets for treatment of, 44
intake, NSP209 NEURAL TUBE DEFECTS
U.S. policy on folic acid used to prevent, NSP358
MALNUTRITION NEUROENDOCRINE
human immunodeficiency virus and, NGR226 aging and changes in, LRA1
in Iraqi children after Gulf War, SA74 body composition and, LRA1
marginal, effect on human function, LRA255 NEUROPATHY
world declaration on, SR41 optic and peripheral, in Cuba, role of nutritional
MANGANESE deficiency in, SA349
effect of dietary iron on, 86 role of cobalamin deficiency in pathogenesis of, NGR12
MENKES DISEASE NIACIN
candidate gene accountable for, 235 as cholesterol-lowering medication, NSP246
META-ANALYSIS NITRIC OXIDE
of studies on association of dietary fiber intake and altered interaction with vascular smooth muscle cells
colorectal cancer risk, 147 caused by copper deficiency, 188
METHEMOGLOBIN REDUCTASE NUTRIENT CONTENT CLAIMS
NADH-dependent, protective effect of riboflavin FDA’s final regulations on, SR101
mediated by, 149 NUTRIENT INTAKE
METHYL-GROUP DEFICIENCY European Community guidelines for, NSP209
cobalamin neuropathy related to, NGR12 NUTRITION
MEXICO in disasters, recommendations dealing with, NSP116
study of marginal malnutrition and human function international conference on, NSP118, NSP122
in, LRA255 neuropathy in Cuba and deficiency in, SA349
MICRONUTRIENTS world declaration on, SR41
in developing countries, inadequate intake of, NUTRITION COLLABORATIVE RESEARCH
LRA255 SUPPORT PROGRAM (CRSP)
MINERAL SUPPLEMENTATION effects of marginal malnutrition on human function
effect on immune response and risk of infection in studied by, LRA255
elderly, 106 NUTRITION GRAND ROUNDS
MINERALS Gorbach, SL, Knox, TA, and Roubenoff, R:
FDA’s proposed regulations of, NSP278, NSP310 ‘Interactions Between Nutrition and Infection
safety limits for intake of, NSP278 with Human Immunodeficiency Virus,’’ NGR226
MONOUNSATURATED FATTY ACIDS Metz, J: ‘‘Pathogenesis of Cobalamin Neuropathy:
effect on arrhythmia in rats, 271 Deficiency of Nervous System
MORTALITY S-Adenosylmethionine?’’ NGR12
body weight and, LRA127 NUTRITION LABELING
MULTIPLE SCLEROSIS FDA’s final reguiations on, SR101
role of iron in, LRA157 NUTRITION RESEARCH
MYOCARDIAL INFARCT new paradigms for, LRA287
normal iron status and risk of, 112 NUTRITION-SCIENCE-POLICY
Dietary Supplements: Rationale for Regulation,
n—3 FATTY ACIDS NSP310
effect on cardiac arrhythmia in rats, 271 Fiber and Colon Cancer: Does the Current Evidence
role in development of human nervous system, 238 Justify a Preventive Policy?, NSPS6
N-METHYL-D-ASPARTATE (NMDA) RECEPTOR Folate and Neural Tube Defects: US Policy Evolves,
effect of vitamin B, deficiency on function of, NSP358
LRA193 New Recommendations for the Diagnosis and
role in long-term potentiation, LRA193 Treatment of Plasma Lipid Abnormalities,
N-RETINYLIDENE-N-RETIN YLETHANOLAMINE NSP246
component of lipofuscin in retina, 205, LE348 Proposed Nutrient and Energy Intakes for the
NATIONAL CENTER FOR HEALTH STATISTICS European Community: A Report of the Scientific
(NCHS) Committee for Food of the European
as reference standard for determining health of Community, NSP209
infants, 52 Recommendations Dealing with Nutrition and Relief
NATIONAL DISASTERS Operations in Times of Disaster, NSP116
recommendations dealing with nutrition and relief Reducing Food>Sorne Disease—What Are the
operations in, NSP116 Priorities? NSP346
Nutrition Reviews, Vol. 51, No. 12
Safety Limits for Nutrient Intakes: Concepts and for vitamin C, LRA313
Data Requirements, NSP278 vitamin/mineral supplementation of elderly above,
The FDA’s Final Regulations on Health Claims for 106
Foods, NSP90 RED WINE
The International Conference on Nutrition: A inhibition of LDL oxidation by phenolic substances
Nongovernmental Perspective, NSP118 in, 185
The International Conference on Nutrition: Giving REFERENCE DAILY INTAKE
Nutrition a Human Face, NSP122 FDA’s final regulations on nutritional labeling and,
SR101
OBESITY 9-cis-RETINOIC ACID
diet and exercise and, SA296 as ligand for retinoic acid receptors (RXRs), 81
increased mortality and morbidity and, LRA127 role in regulation of 1,25-dihydroxyvitamin D,, 303
self-reported and actual energy intake and physical RETINOIC ACID-X RECEPTORS (RXR)
activity in, SA296 discovery and functions of, 81
OLIGODENDROCYTES role in regulation of 1,25-dihydroxyvitamin D,, 303
role in multiple sclerosis, LRA157 RETINOL
OLIGOFRUCTOSE dietary equivalency of carotenes in terms of, SA199
biochemistry of, SA137 RHEUMATOID ARTHRITIS
caloric value of, SA137 neuroendocrine and immune mediators of metabolism
OSTEOPOROSIS and, LRAI
calcium and vitamin D, supplementation for, 183 vitamin B, deficiency and, LRA217
FDA authorization of food labeling health claim with RIBOFLAVIN
respect to, NSP90 cataracts in women and intake of, 84
OTITIS MEDIA protects tissues against oxidative injury by
effect of breast feeding on incidence of, 27° hemeproteins, 149
OXIDATIVE INJURY
from absorption of lipid oxidation products, LRA33 S-ADENOSYLMETHIONINE DEFICIENCY
riboflavin protects tissues against, 149 role in cobalamin neuropathy, NGR12
to brain, role of iron in, LRA157 SAFETY LIMITS
vitamin E status and, LRA33 of nutrient intake, concepts and data requirements of,
NSP278
PHENOLS SANITATION
in red wine, LDL oxidation inhibited by, 185 role in growth of children in developing countries,
POLYUNSATURATED FATTY ACIDS SA327
atherosclerosis risk and oxidation of, LRA33 SATIETY
protect against arrhythmia in rats. 271 role of apolipoprotein A-IV in, 273
POPULATION REFERENCE INTAKE SATURATED FAT
proposed value for European Community nutrient food label health claims with respect to coronary
intake, NSP209 heart disease and, NSP90
PRETERM DELIVERY SATURATED FATTY ACIDS
iron-deficiency anemia increases risk of, 49 effect on arrhythmia in rats, 271
PROLACTIN SHORT-CHAIN FATTY ACIDS
age-related body composition and changes in, LRAI as fermentation product of oligofructose,
PROVITAMIN A biochemistry of, SA137
human nutriture and plant sources of, SA199 SOY PROTEIN
PUBLIC HEALTH hyperlipidemia of nephrotic syndrome treated with
mainutrition—infection complex in developing diet of, 44
countries as problem in, SA327 SPECIAL (SIGNED) ARTICLES
PYRROLOQUINOLINE QUINONE (PQQ) Forbes, GB: ‘‘Diet and Exercise in Obese Subjects:
in mammalian systems, electron transport and, LE26 Self-Report Versus Controlled Measurements,
SA296
RATS Matkovic, V, and Ilich, JZ: ‘‘Calcium Requirements
dietary fatty acids and protection against for Growth: Are Current Recommendations
experimental cardiac arrhythmias in, 271 Adequate?’’ SA171
effect of vitamin B, deficiency on postnatal Roberfroid, M, Gibson, GR, and Delzenne, N: ‘‘The
development and brain of, LRA193 Biochemistry of Oligofructose, a Nondigestible
glutamine in parenteral solutions enhances intestinal Fiber: An Approach to Calculate Its Caloric
mucosal immune function in, 152 Value,’’ SA137
low-copper diets increase aortic lipid peroxides in, 88 Solomons, NW, and Bulux, J: ‘‘Plant Sources of
satiating effect of fats tested in, 181 Provitamin A and Human Nutriture,’’ SA199
RECOMMENDED DIETARY ALLOWANCES (RDA) Solomons, NW, Mazariegos, M, Brown, KH,
for calcium, peak bone mass and, SA171 Klasing, K: ‘““The Underprivileged, Developing
Nutrition Reviews, Vol. 51, No. 12
Country Child: Environmental Contamination VEGETABLE OILS
and Growth Failure Revisited,’’ SA327 hydrogenated versus unhydrogenated, role in
Smith, MC, and Zaidi, S: ‘‘Malnutrition in Iraqi cardiovascular disease, 340, 344
Children Following the Gulf War: Results of a VEGETABLES
National Survey,’’ SA74 bioconversion of carotenoids from, SA199
Tucker, K, and Hedges, TR: ‘‘Food Shortages and FDA regulation of health claims of, NSP90
an Epidemic of Optic and Peripheral Neuropathy VITAMIN A
in Cuba,’’ SA349 bioconversion of carotenoids to, SA199
SPECIAL REPORTS decreased risk of cataract with intake of, 84
Mandatory Nutrition Labeling—-FDA’s Final Rule, plant versus animal sources of, SA199
SR101 role of cellular retinol-binding protein type II in
World Declaration on Nutrition, SR41 metabolism of, 81
STEM-AND-LOOP STRUCTURE VITAMIN B,
of ferritin mRNAs, interaction with IRE-BP, LRA65 brain and cognitive development and, LRA193
SUNFLOWER SEED OIL VITAMIN B, DEFICIENCY
protection against cardiovascular disease, 271 during gestation and lactation, effect on
SUPEROXIDE DISMUTASE (SOD1) GENE N-methyl-D-aspartate receptors, LRA193
role of mutations of in familial amyotrophic lateral immune competence and, LRA217
sclerosis, 243 VITAMIN C (see also ASCORBIC ACID)
cataracts in women and intake of, 84
T-CELL PROLIFERATION colorectal cancer risk and di«tary intake of, 147
copper-deficiency-induced impaired production of new roles and new requirements for, LRA313
IL-2 decreases, 307 VITAMIN D, SUPPLEMENTATION
TAURINE UPTAKE hip fractures in elderly women prevented by, 183
role of loss of carrier-mediated intestinal taurine VITAMIN E
transport in adult cats and, 22 as protector of polyunsaturated fatty acids against
TOTAL PARENTERAL NUTRITION oxidation, LRA33
glutamine-enriched, effect on intestinal mucosal cataracts in women and intake of, 84
immune function, 152 VITAMIN E DEFICIENCY
nutritional support of AIDS patients using, NGR226 increase in lipofuscin and, 205, LE348
TOXINS VITAMIN E SUPPLEMENTATION
role in neuropathy epidemic in Cuba, SA349 coronary heart disease and, 333
TRACE METALS effect on glucose utilization and hepatic response to
deficiency and essentiality of, LRA287 insulin, 339
research activities on, LRA287 VITAMIN SUPPLEMENTATION
trans FATTY ACIDS bioavailability of nutrients from, 301
cardiovascular disease and, 340, 344 coronary heart disease and, 333
TRANSFERRIN effect on immune response and risk of infection in
role in iron distribution in brain, LRA157 elderly, 106
TRANSFERRIN RECEPTORS VITAMINS
role in iron distribution in brain, LRA157 FDA’s proposed regulations of, NSP278, NSP310
TRIACYLGLYCEROL safety limits for intake of, NSP278
feedback control of lipoprotein lipase activity by free
fatty acids released by hydrolysis of, 18 WHOLE OXIDIZED OILS
TUMOR NECROSIS FACTOR atherogenesis and, LRA33
age-related body composition and changes in, LRAI
YOUNG ADULTS
ULCERATIVE COLITIS
calcium intake and skeletal mass of, SA171
role of marine fish oils in treating, 47
in developing countries, growth predictors for,
UREMIA
LRA255
vitamin B, deficiency and, LRA217
VASCULAR FUNCTION ZINC DEFICIENCY
copper deficiency and impairment of, 188 effect on growth performance, 268
Nutrition Reviews, Vol. 51, No. 12
December 1993: 370
Author Index to Volume 51
A prefix indicating the type of contribution may precede the page number as follows:
NSP: Nutrition-Science-Policy NGR: Nutrition Grand Rounds
SA: Special (Signed) Article SR: Special Report
LRA: Lead Review Article LE: Letter to the Editor
Allien, LH, LRA255 Gorbach, SL, NGR226 Messer, E, NSP118
Ausman, LM, NSP57 Guilarte, TR, LRA193 Metz, J, NGR12
Meydani, SN, LRA217
Beard, JL, LRA157 Hathcock, JN, NSP278 Misfeldt, M, LE24
Bissell, RE, NSP122 Huang, SC, LE24 Munro, H, LRA65
Brown, KH, SA327
Bulux, J, SA199 llich, JZ, SA171 Newmark, H, LE213
International Conference on
Christensen, HN, LRA9S Nutrition, SR41 Rall, LC, LRA1, LRA217
Connor, JR, LRAI57
Roberfroid, M, SA137
Jones, BC, LRA!57 Rosenberg, IH, NSP209
Delzenne, N, SA137
Roubenoff, R, LRA1, LE25,
Doyle, MP, NSP346
Klasing, K, SA327 NGR226
Knox, TA, NGR226
Evans, WJ, LE25
Kubow, S, LRA33 Schaefer, EJ, NSP246
Kushner, RF, LRA127 Smith, MC, SA74
Fliickiger, R, LE26
Solomons, NW, SA199, SA327
Food and Drug Administration,
NSP90, SR101 Lipkin, M, LE213
Forbes, GB, SA296 Tucker, K, SA349
Fritsche, KL, LE24 Matkovic, V, SA171
Mayer, J, NSP116 Wolf, G, LE348
Gershoff, SN, LRA313 Mazariegos, M, SA327
Gibson, GR, SA‘37 Mertz, W, LRA287 Zaidi, S, SA74
Nutrition Reviews, Vol. 51, No. 12